Remdesivir reduces COVID-19 mortality in a real-world setting

Researchers have discovered that administering remdesivir with corticosteroids to Asian sufferers who’re critically in poor health with COVID-19 inside 9 days of symptom onset reduces general mortality. Beginning therapy later didn’t have the identical impact, suggesting that increased viral hundreds and severe lung injury impair the effectiveness of this therapy.